Reproductive Futures: The Promises and Pitfalls of In-Vitro Gametogenesis
By Sarojini Nadimpally and Gargi Mishra,
The Wire
| 12. 15. 2024
Although IVG is still a new technology, its probable risks and potential for misuse in a regulatory vacuum call for caution rather than any call for optimism.
In-vitro fertilisation (IVF) as assisted reproductive technology (ART) has been in vogue for quite a few decades now. While IVF has been hailed as a significant scientific advancement, with many advantages, here are some limitations which bear keeping in mind in discussions about the possibilities and extent of its use in the present and the future.. It is in this context that we discuss in-vitro gametogenesis (IVG) – a new experimental reproductive technology that is currently being developed and refined, and thus debated on a number of different fronts.
The concerns about reproductive autonomy, ethics, and equity ought to be at the forefront of any discussion of advanced and experimental reproductive technologies, including IVG. Although IVG is not currently under research in India, this technology is gaining more attention in the global scientific community. Thus, it becomes imperative to engage with it critically.
Researchers claim that IVG would reduce the risks of IVF procedures by creating sperm and oocytes (eggs) directly in a lab, unlike in the case of the IVF, which requires the retrieval of eggs from ovaries, and...
Related Articles
By Erik Adams, Sundance | 09.08.2026
The scariest movie playing at the 2026 Sundance Film Festival isn’t about cursed audio recordings or a killer demon disguised as your true love; rather it’s a 110-minute essay film about how a handful of guys obsessed with numbers and...
By Katie Bo Lillis and Zachary Cohen, CNN | 09.18.2026
The intelligence report, circulated across the US military this spring in the midst of the war with Iran, immediately set off alarm bells: A Chinese ship in the Middle East was transporting components of a nuclear weapons program.
The US...
By Miryam Naddaf, Nature | 09.21.2026
A wave of epigenetic therapies is offering hope as ways to cure chronic hepatitis B — a lingering liver infection that is caused by the hepatitis B virus (HBV) and affects more than 250 million people around the world. Currently...
By Karen Weintraub, Endpoints News | 09.16.2026
To better understand certain neuropsychiatric disorders, researchers at Stanford University have bred rodents that lack a cortex and hippocampus and then replaced those missing brain cells with human ones.
The altered mice, a scientific first, provided insights that would not...